Cantargia Appoints Dr. Monic Stuart as Chief Medical Officer
LUND, SE / ACCESS Newswire / October 26, 2026 / Cantargia AB (publ)(STO:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today announced the appointment of Monic Stuart, MD, PhD, MBA as Chief …
Weiterlesen »